Use of Risk Management to Meet Requirements of IEC 60601-1 This presentation will examine the requirements of IEC 60601-1 for use of ISO 14971 risk management and interpret those requirements. Live
Thursday,
August 26, 2010
10:00 AM PDT | 01:00 PM EDT,
Duration:90 Minutes
Construction of the European Drug Master File (eDMF) for Regulatory Agencies Drug master files serve as documentation on the quality of an active ingredient or excipient and are submitted by a manufacturer as part of the licensing or amendment procedure. Live
Tuesday,
August 31, 2010
09:00 AM PDT | 12:00 PM EDT,
Duration:60 Minutes
Conducting Value Added Audits of Technical Service Providers This presentation will address conducting value added audits of technical service providers (TSPs) providing services for and/or in support of clinical trials and programs. Live
Tuesday,
August 31, 2010
10:00 AM PDT | 01:00 PM EDT,
Duration:60 Minutes
Good Documentation Practices for GMP Operations Whether you work in production or in a laboratory or if you conduct investigations or finalize product release, sound data and information is essential to success and compliance. Live
Thursday,
September 2, 2010
10:00 AM PDT | 01:00 PM EDT,
Duration:60 Minutes
Corporate Governance & Compensation in Risk Management This session will provide an overview of the major tenants of corporate board governance, structure, organization, and composition and how each of these relates to an enterprise's ability to balance risk and opportunities while acting in an ethical and pr Live
Tuesday,
September 7, 2010
10:00 AM PDT | 01:00 PM EDT,
Duration:90 Minutes
Post-Design Medical Device Risk Management In this presentation we will explore the requirements for post-design risk management and determine how to apply the requirements. Live
Tuesday,
September 7, 2010
10:00 AM PDT | 01:00 PM EDT,
Duration:90 Minutes
Key Modules of an Effective CAPA SOP This webinar will examine the stated intent of the Agency to get tougher across the board in its expectations for the medical industry and its compliance to the cGMPs, especially CAPA. Live
Wednesday,
September 8, 2010
10:00 AM PDT | 01:00 PM EDT,
Duration:60 Minutes
Effective & Essential CAPA process to avoid FDA 483 How do you prevent becoming another FDA statistic? Poor corrective and preventive action (CA/PA) and investigations continue to be among top FDA Form 483 deficiencies issued to drug, biologic, and medical device manufacturers. Live
Wednesday,
September 8, 2010
10:00 AM PDT | 01:00 PM EDT,
Duration:60 Minutes
Verification of Pharmacopeia Methods Laboratories that work in a GMP environment are required to have documentation to show they are qualified to run specific, consistent and reliable analytical test methods. Live
Thursday,
September 9, 2010
10:00 AM PDT | 01:00 PM EDT,
Duration:90 Minutes
Signal Detection and Data Mining This webinar will cover the fundamentals of signal detection, and how these can be augmented by the use of data mining techniques. Live
Thursday,
September 9, 2010
10:00 AM PDT | 01:00 PM EDT,
Duration:90 Minutes
Understanding Acceptance Activities for Medical Devices Acceptance activities are common in device manufacturing, but seem to cause problems for some manufacturers. These problems range from simple instances of lack of procedures or acceptance criteria to misapplication of statistical methods. Live
Tuesday,
September 14, 2010
10:00 AM PDT | 01:00 PM EDT,
Duration:75 Minutes
Physical Properties Analytical and Screening Techniques The chemical composition of the active ingredient of a pharmaceutical dosage form determines the efficacy and stability of the formulation however during manufacturing it is the physical properties of the formulation components that are critical in the un Live
Tuesday,
September 14, 2010
10:00 AM PDT | 01:00 PM EDT,
Duration:60 Minutes
How to Audit API Manufacturers and Suppliers This program will focus on the basics needed to perform an API audit. Performing an audit is not simply an act of visiting a firm and checking off a list of questions. Live
Tuesday,
September 14, 2010
10:00 AM PDT | 01:00 PM EDT,
Duration:60 Minutes
Troubleshooting ethylene oxide (EO) processes Not every parameter in the EO sterilization process in critical for the determination of the SAL. This presentation will outline the various parameters and what actions should be taken when they are not compliant to the process specification. Live
Wednesday,
September 15, 2010
10:00 AM PDT | 01:00 PM EDT,
Duration:60 Minutes
Law Enforcement and Pain Management Class participants will familiarize themselves with the federal laws and regulations enforced by DEA pertaining to Schedules II though V controlled substances that are dispensed, or prescribed by a physician as part of a pain treatment plan. Live
Thursday,
September 16, 2010
10:00 AM PDT | 01:00 PM EDT,
Duration:90 + 15 Minutes Q&A
Why Medical Device Companies Receive Warning Letters The Commissioner of the US FDA has stated the agency will be more enforcement oriented and quicker to issue Warning Letters. This presentation will review current enforcement practices of the US FDA with actual Warning Letters recently issued to medical d Live
Tuesday,
September 21, 2010
10:00 AM PDT | 01:00 PM EDT,
Duration:90 Minutes
Quality by Design (QbD) and Analytical Methods As the industry is moving towards applying Quality by Design (QbD) to process development, the question must be asked: Is this also the way forward to revolutionise, improve and standardise our approach to method development and qualification? Live
Tuesday,
September 21, 2010
10:00 AM PDT | 01:00 PM EDT,
Duration:90 Minutes
Auditing Computer System Validation Materials This presentation will provide auditors who are not knowledgeable about computer system validation with a basic understanding of the requirements and expectations for validation documentation. Live
Tuesday,
September 21, 2010
10:00 AM PDT | 01:00 PM EDT,
Duration:60 Minutes
Managing the IDE (Investigational Device Exemption) Submission for Compliance Success An investigational device exemption (IDE) allows the investigational device to be used in a clinical study in order to collect safety and effectiveness data required to support a Premarket Approval (PMA) application or a Premarket Notification [510(k)] su Live
Tuesday,
September 21, 2010
10:00 AM PDT | 01:00 PM EDT,
Duration:60 Minutes
Preparing for FDA Inspections in a Changing Regulatory Environment Ready for Inspection by Hamburg's FDA? Under Commissioner Hamburg's new enforcement policy, FDA has issued more warning letters more quickly than it has in years. Live
Wednesday,
September 22, 2010
10:00 AM PDT | 01:00 PM EDT,
Duration:60 Minutes
Developing and Implementing an Effective Product Specification A good specification not only defines the product and process being purchased by the customer, but also serves as an extension of the purchasing contract. Live
Thursday,
September 23, 2010
10:00 AM PDT | 01:00 PM EDT,
Duration:60 Minutes
Environmental and Product Compliance - Sustainability Many leading organizations have recognized the need to manage environmental risks and demonstrate a commitment to sustainability and related environmental compliance. Live
Thursday,
September 23, 2010
10:00 AM PDT | 01:00 PM EDT,
Duration:90 Minutes
Outsourced processes and ISO 9001:2008 In 2008, a new edition of ISO 9001 went into effect. The literature says the new version doesn't introduce any new requirements but only clarifications to the existing requirements. Live
Tuesday,
September 28, 2010
10:00 AM PDT | 01:00 PM EDT,
Duration:75 Minutes
Robust Process Validation for Medical Devices One of the most common reasons noted by the FDA for recalls of medical device is improper validation. Live
Tuesday,
September 28, 2010
10:00 AM PDT | 01:00 PM EDT,
Duration:60 Minutes
Preparing for and Surviving an FDA Inspection The purpose of the FDA inspection is a verification activity that should demonstrate to the regulatory agency and provide assurance that products consistently meet quality expectations and that your company is operating in a consistent and compliant state Live
Tuesday,
September 28, 2010
10:00 AM PDT | 01:00 PM EDT,
Duration:60 Minutes
How to Manage a Product Medical Device Recall Efficiently and Effectively Recall means the correction or removal of a device for human use where FDA finds that there is a reasonable probability that the device would cause serious, adverse health consequences or death. Live
Thursday,
September 30, 2010
10:00 AM PDT | 01:00 PM EDT,
Duration:60 Minutes
The HITECH Acts Impact on HIPPA The new requirements of the HITECH Act have a significant impact on the privacy and security of health information. Live
Thursday,
October 14, 2010
10:00 AM PDT | 01:00 PM EDT,
Duration:60 Minutes